High-definition Transcranial Direct Current Stimulation for Facilitating Hand Function Recovery After Stroke

Sponsor
Chinese University of Hong Kong (Other)
Overall Status
Completed
CT.gov ID
NCT03875677
Collaborator
(none)
25
1
3
13.7
1.8

Study Details

Study Description

Brief Summary

Transcranial direct current stimulation (tDCS) had recently been shown having feasibility in modulating cortical excitability transiently during motor training in a noninvasive way. The findings support that tDCS and motor practice can positively promote post-stroke motor learning to improve upper-limb motor recovery after stroke. A randomized controlled trial will be conducted with three groups: HD-tDCS, conventional tDCS and sham HD-tDCS. A 10-session training will be provided to evaluate the effectiveness of transient modulation of cortical excitability through tDCS with clinical assessment scores.

Condition or Disease Intervention/Treatment Phase
  • Device: HD-tDCS group
  • Device: Conventional tDCS group
  • Device: Sham HD-tDCS group
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Using Neuroimage and Computational Modeling to Customize High-definition Transcranial Direct Current Stimulation Protocols for Facilitating Hand Function Recovery After Stroke
Actual Study Start Date :
Apr 10, 2019
Actual Primary Completion Date :
Jun 1, 2020
Actual Study Completion Date :
Jun 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: HD-tDCS group

Constant current (1mA) will be applied for 20min and the anode will be placed over the defined target area

Device: HD-tDCS group
5 sintered Ag/AgCl ring electrodes will be used at a radius of ~5cm. The electrodes will be placed inside plastic electrode holders which will be filled with gel to have better contact with the scalp.

Experimental: Conventional tDCS group

Constant current (1mA) will be applied for 20min and the anode will be placed over the standard C3/C4 position

Device: Conventional tDCS group
A pair of 25 cm2 rubber electrodes enclosed in saline-soaked sponges and affixed to the head with rubber bands.

Sham Comparator: Sham HD-tDCS group

The stimulator will be shut down after 30s of stimulation. The patients will feel the initial itching sensation at the beginning in order to evaluate the placebo effect.

Device: Sham HD-tDCS group
A pair of 25 cm2 rubber electrodes enclosed in saline-soaked sponges and affixed to the head with rubber bands.

Outcome Measures

Primary Outcome Measures

  1. Action Research Arm Test (ARAT) [3-month after the 10th session training]

    The ARAT has total 19 items, divided into 4 categories (grasp, grip, pinch, and gross arm movement). It ranges from 3 to 0 (best to worse).

Secondary Outcome Measures

  1. Fugl-Meyer Assessment (Upper Extremity) [3-month after the 10th session training]

    The maximum score is 66, divided into 33 items in the form of a 3-point scale (0-2), 0 is cannot perform and 2 performs fully.

  2. Wolf Motor Function Test (WMFT) [3-month after the 10th session training]

    The WMFT measures upper limb ability through timed and functional tasks. It has 17 items, ranging from 0 to 5 (worse to best).

  3. Magnetic Resonance Imaging [Baseline]

    Functional magnetic resonance imaging

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Hemiparesis subsequent to first-ever unilateral stroke for more than 6 months;

  2. MCP and PIP finger joints can be extended to 180° passively;

  3. Sufficient cognition to follow the experimental instructions

Exclusion Criteria:
  1. Severe hand spasticity or hand deformity;

  2. History of alcohol or drug abuse or epilepsy;

  3. Bilateral brain infarcts;

  4. Severe cognitive deficits;

  5. Comprehensive aphasia;

  6. Contraindications to tDCS

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Biomedical Engineering, The Chinese University of Hong Kong Shatin Hong Kong

Sponsors and Collaborators

  • Chinese University of Hong Kong

Investigators

  • Principal Investigator: Raymond Tong, PhD, Department of Biomedical Engineering, CUHK

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Raymond KY Tong, Chairman and Professor, Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT03875677
Other Study ID Numbers:
  • 2017.155
First Posted:
Mar 15, 2019
Last Update Posted:
Sep 13, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2021